Taconic Acquires Subsidiary of Caliper Life Sciences (NASDAQ: CALP)

Taconic, one of the largest laboratory rodent providers in the world, announced it has recently acquired Xenogen Biosciences Corporation, a wholly-owned subsidiary of Caliper Life Sciences, Inc. (NASDAQ: CALP).

Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.

Xenogen Biosciences is a provider of in vivo drug discovery services, including in vivo target and compound evaluation and the design, production and phenotyping of genetically modified animal models. The acquisition was completed on December 11th. The move enables Taconic to expand its genetically modified model generation, production and phenotyping capabilities through access to new models and the addition of a U.S. production site. Pursuant to a separate distribution agreement, Taconic will also cryopreserve, breed and distribute Caliper's Light Producing Transgenic Animals (LPTA® models), a unique line of models that use bioluminescent technology to improve oncology, inflammation, metabolic and endocrine disease research and drug toxicology studies. Imaging studies using these models will be conducted at an AAALAC-accredited vivarium in Cranbury, New Jersey -- part of a 50,000-square-foot facility acquired under the agreement.

Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

Follow us on Twitter: http://www.Twitter.com/topbestps

About Us

Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

Please click here to read the full disclaimer.